Revenue GrowthConsolidated revenues rose by 4.8% yoy, while the adjusted EBITDA margin improved to 16.8%, supported by a significant acceleration in 2Q25.

Bears Say

Nutra Segment ChallengesA more cautious stance is warranted for the Nutra sector, as the nutraceutical segment dedicated to weight control products is being redefined.

Top Line Trend ConcernsThe Nutra segment dedicated to weight management is undergoing a repositioning, leading to a more cautious stance on the FY top line trend.

Fine Foods & Pharmaceuticals N.T.M. SpA News

Strong Financial Performance and Strategic Growth Drive Buy Rating for Fine Foods & Pharmaceuticals N.T.M. SpA

Analyst Giorgio Tavolini of Intermonte maintained a Buy rating on Fine Foods & Pharmaceuticals N.T.M. SpA, boosting the...

3M ago

Strong Performance and Strategic Growth Drive Buy Rating for Fine Foods & Pharmaceuticals N.T.M. SpA

Analyst Giada Cabrino of Intesa Sanpaolo maintained a Buy rating on Fine Foods & Pharmaceuticals N.T.M. SpA (FF...

6M ago

Strong Buy Recommendation for Fine Foods & Pharmaceuticals N.T.M. SpA: Strategic Positioning and Financial Performance Drive Positive Outlook

Fine Foods & Pharmaceuticals N.T.M. SpA (FF – Research Report), the Consumer Defensive sector company, was revisited by...

8M ago

Fine Foods Reports Strong Growth in 2024 Financials

Fine Foods & Pharmaceuticals N.T.M. SpA (IT:FF) has released an update. Fine Foods & Pharmaceuticals N.T.M. S.p.A. reported...

12M ago

FF FAQ

What was Fine Foods & Pharmaceuticals N.T.M. SpA’s price range in the past 12 months?

Fine Foods & Pharmaceuticals N.T.M. SpA lowest stock price was €6.46 and its highest was €9.62 in the past 12 months.

What is Fine Foods & Pharmaceuticals N.T.M. SpA’s market cap?

Fine Foods & Pharmaceuticals N.T.M. SpA’s market cap is €228.29M.

When is Fine Foods & Pharmaceuticals N.T.M. SpA’s upcoming earnings report date?

Fine Foods & Pharmaceuticals N.T.M. SpA’s upcoming earnings report date is Mar 26, 2026 which is in 138 days.

How were Fine Foods & Pharmaceuticals N.T.M. SpA’s earnings last quarter?

Currently, no data Available

Is Fine Foods & Pharmaceuticals N.T.M. SpA overvalued?

According to Wall Street analysts Fine Foods & Pharmaceuticals N.T.M. SpA’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Fine Foods & Pharmaceuticals N.T.M. SpA pay dividends?

Fine Foods & Pharmaceuticals N.T.M. SpA pays a Annually dividend of €0.14 which represents an annual dividend yield of 1.53%. See more information on Fine Foods & Pharmaceuticals N.T.M. SpA dividends here

What is Fine Foods & Pharmaceuticals N.T.M. SpA’s EPS estimate?

Fine Foods & Pharmaceuticals N.T.M. SpA’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Fine Foods & Pharmaceuticals N.T.M. SpA have?

Fine Foods & Pharmaceuticals N.T.M. SpA has 22,060,125 shares outstanding.

What happened to Fine Foods & Pharmaceuticals N.T.M. SpA’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Fine Foods & Pharmaceuticals N.T.M. SpA?

Currently, no hedge funds are holding shares in IT:FF

Company Description

Fine Foods & Pharmaceuticals N.T.M. SpA

Fine Foods & Pharmaceuticals N.T.M. SpA (FF) is an Italian company that specializes in the contract development and manufacturing of products in the nutraceutical, pharmaceutical, and cosmetics sectors. The company offers a wide range of services including the formulation, production, and packaging of an array of products such as dietary supplements, over-the-counter pharmaceuticals, and beauty products. FF is known for its commitment to quality, innovation, and sustainable practices, providing tailored solutions to meet the specific needs of its clients.